Company news

CelLBxHealth plc news in 2016

CelLBxHealth plc's news releases, calls and decks from 2016, newest first.

View company

Issue of share options

November 28, 2016

Result of GM

November 24, 2016

Barts Research Supports Potential Use of Parsortix

November 4, 2016

Notice of GM

November 1, 2016

Director's share purchase

October 27, 2016

Research published in Clinical Chemistry

September 30, 2016

Annual Report and Accounts and Notice of AGM

September 9, 2016

MD Anderson Cancer Center poster presentation

August 4, 2016

Edison issues ADR update on Angle

August 2, 2016

Use of Parsortix in GANNET53 drug trial

July 28, 2016

Initiation of 200 patient US ovarian cancer study

July 27, 2016

Initiation of European ovarian cancer study

July 19, 2016

Parsortix gaining traction at EACR Conference

July 15, 2016

Edison issues research update on Angle

May 27, 2016

Cancer Research UK Contract

May 25, 2016

New publications utilising Parsortix

April 29, 2016

Parsortix potential in metastatic breast cancer

April 18, 2016

Parsortix potential for prostate cancer detection

March 21, 2016

European patent grant for Parsortix

March 9, 2016

Notice of Interim Results

January 27, 2016

UKE publishes evaluation of Parsortix

January 25, 2016

Decks in 2016